Antitumor vaccination using peptide based vaccines

被引:21
作者
Eisenbach, L [1 ]
Bar-Haim, E [1 ]
El-Shami, K [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
TAA; peptides; CTL; immunotherapy; vaccines;
D O I
10.1016/S0165-2478(00)00245-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytotoxic T Lymphocytes (CTLs) recognize Major Histocompatibility Complex (MHC) class I in complex with peptides. Peptides derived from Tumor Associated Antigens (TAAs) are therefore targets for tumor rejection. A number of TAAs were identified in the last decade from human and murine tumors. Here we summarize the methods for TAA and peptide identification, the nature of TAA peptides and the making of antitumor vaccines. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
[1]   Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes [J].
Blake, J ;
Johnston, JV ;
Hellstrom, KE ;
Marquardt, H ;
Chen, LP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :121-130
[2]   Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma [J].
Bloom, MB ;
PerryLalley, D ;
Robbins, PF ;
Li, Y ;
ElGamil, M ;
Rosenberg, SA ;
Yang, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :453-459
[3]   BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES [J].
BOEL, P ;
WILDMANN, C ;
SENSI, ML ;
BRASSEUR, R ;
RENAULD, JC ;
COULIE, P ;
BOON, T ;
VANDERBRUGGEN, P .
IMMUNITY, 1995, 2 (02) :167-175
[4]  
BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.iy.12.040194.002005
[5]  
Carmon L, 2000, INT J CANCER, V85, P391
[6]   IMMUNITY TO ONCOGENIC PROTEINS [J].
CHEEVER, MA ;
DISIS, ML ;
BERNHARD, H ;
GRALOW, JR ;
HAND, SL ;
HUSEBY, ES ;
QIN, HL ;
TAKAHASHI, M ;
CHEN, W .
IMMUNOLOGICAL REVIEWS, 1995, 145 :33-59
[7]   Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions [J].
Chen, AI ;
McAdam, AJ ;
Buhlmann, JE ;
Scott, S ;
Lupher, ML ;
Greenfield, EA ;
Baum, PR ;
Fanslow, WC ;
Calderhead, DM ;
Freeman, GJ ;
Sharpe, AH .
IMMUNITY, 1999, 11 (06) :689-698
[8]  
Chen PW, 1996, J IMMUNOL, V156, P224
[9]   Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: Implications for tumor immunotherapy [J].
Colella, TA ;
Bullock, TNJ ;
Russell, LB ;
Mullins, DW ;
Overwijk, WW ;
Luckey, CJ ;
Pierce, RA ;
Restifo, NP ;
Engelhard, VH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (07) :1221-1231
[10]   IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES [J].
COX, AL ;
SKIPPER, J ;
CHEN, Y ;
HENDERSON, RA ;
DARROW, TL ;
SHABANOWITZ, J ;
ENGELHARD, VH ;
HUNT, DF ;
SLINGLUFF, CL .
SCIENCE, 1994, 264 (5159) :716-719